share_log

EF Hutton Initiates Coverage On Citius Pharma With Buy Rating, Announces Price Target of $6

EF Hutton Initiates Coverage On Citius Pharma With Buy Rating, Announces Price Target of $6

EF哈顿启动对Citius Pharma的买入评级覆盖,公布6美元的目标价。
Benzinga ·  07/15 09:44

EF Hutton analyst Jason Kolbert initiates coverage on Citius Pharma (NASDAQ:CTXR) with a Buy rating and announces Price Target of $6.

EF哈顿分析师Jason Kolbert以买入评级启动了对Citius Pharma(纳斯达克:CTXR)的覆盖,并宣布6美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发